Cross-fund · 5 holders
MYGN
MYRIAD GENETICS INC
CUSIP 62855J104
5
Tracked holders
$127.1M
Aggregate value
25,232,575
Shares
5
Active funds
Funds holding MYGN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $50.6M | — | +342,856 | +4.3% |
| BlackRock | Institutional | Q1 2026 | $40.0M | — | -6,414,206 | -41.9% |
| Millennium | Multi-Strategy | Q1 2026 | $30.0M | 0.01% | -31,341 | -0.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $4.3M | 0.01% | -274,767 | -22.3% |
| Citadel | Multi-Strategy | Q1 2026 | $2.2M | — | +200,671 | +69.2% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.